25 related articles for article (PubMed ID: 35489437)
1. PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.
Ozawa N; Yokobori T; Osone K; Katayama C; Suga K; Komine C; Shibasaki Y; Shiraishi T; Okada T; Kato R; Ogawa H; Sano A; Sakai M; Sohda M; Ojima H; Miyazaki T; Motegi Y; Ide M; Yao T; Kuwano H; Shirabe K; Saeki H
Sci Rep; 2021 Jun; 11(1):13077. PubMed ID: 34158547
[TBL] [Abstract][Full Text] [Related]
2. The Autoimmune Protocol Diet Modifies Intestinal RNA Expression in Inflammatory Bowel Disease.
Chandrasekaran A; Molparia B; Akhtar E; Wang X; Lewis JD; Chang JT; Oliveira G; Torkamani A; Konijeti GG
Crohns Colitis 360; 2019 Oct; 1(3):otz016. PubMed ID: 32309803
[TBL] [Abstract][Full Text] [Related]
3. Type 2 autoimmune pancreatitis associated with ulcerative colitis.
Nan N; Wang D
Front Immunol; 2023; 14():1288390. PubMed ID: 38124742
[TBL] [Abstract][Full Text] [Related]
4. PD-1-positive cells contribute to the diagnosis of inflammatory bowel disease and can aid in predicting response to vedolizumab.
Kim MK; Jo SI; Kim SY; Lim H; Kang HS; Moon SH; Ye BD; Soh JS; Hwang SW
Sci Rep; 2023 Dec; 13(1):21329. PubMed ID: 38044341
[TBL] [Abstract][Full Text] [Related]
5. Emerging phagocytosis checkpoints in cancer immunotherapy.
Liu Y; Wang Y; Yang Y; Weng L; Wu Q; Zhang J; Zhao P; Fang L; Shi Y; Wang P
Signal Transduct Target Ther; 2023 Mar; 8(1):104. PubMed ID: 36882399
[TBL] [Abstract][Full Text] [Related]
6. Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity.
Zhong G; He C; Wang S; Lin C; Li M
Front Immunol; 2023; 14():1241262. PubMed ID: 37720208
[TBL] [Abstract][Full Text] [Related]
7. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of spatial PD1 and PD-L1 expression in inflammatory bowel disease samples - a pilot study.
Szczepaniak K; Paskal W; Kuśmierczyk Z; Wejman J; Ostrowska J; Tarnowski W; Włodarski P
Pol J Pathol; 2022; 73(1):50-59. PubMed ID: 35848481
[TBL] [Abstract][Full Text] [Related]
9. Over-Expression of Immunosuppressive Molecules, PD-L1 and PD-L2, in Ulcerative Colitis Patients.
Rajabian Z; Kalani F; Taghiloo S; Tehrani M; Rafiei A; Hosseini-Khah Z; Hosseini V; Ajami A
Iran J Immunol; 2019 Mar; 16(1):62-70. PubMed ID: 30864556
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
11. Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
Cassol CA; Owen D; Kendra K; Braga JR; Frankel WL; Arnold CA
Histopathology; 2020 Aug; 77(2):240-249. PubMed ID: 32298485
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease.
Nguyen J; Finkelman BS; Escobar D; Xue Y; Wolniak K; Pezhouh M
Hum Pathol; 2022 Aug; 126():19-27. PubMed ID: 35489437
[TBL] [Abstract][Full Text] [Related]
13. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
